市场调查报告书
商品编码
1547880
全球左心耳封堵器市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Left Atrial Appendage Closure Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球左心耳封堵器市场需求预计将从 2023 年的 22.4 亿美元达到 2032 年近 67.3 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 13.01%。
左心耳封堵装置透过封闭心臟中一个小的、不必要的部分(称为左心耳)来帮助预防中风。此装置可有效消除左心耳血液聚集的可能性。该装置透过手术植入。在全身麻醉下透过各种方法植入不同的左心耳封堵器,这意味着患者在整个手术过程中处于睡眠状态。设备帮助可以从外部角度或内部血液暴露设备来实现。
中风对于心房颤动患者来说是一个严重的风险。如果治疗不当,心房颤动患者发生中风的风险更高。心房颤动 (AFib) 是最广泛认识的心律异常,影响全球超过 3,300 万人。心房颤动的日益普及将推动市场的成长。此外,政府为提高公众对心血管疾病的认识而采取的倡议激增以及有吸引力的健康保险政策可能会影响左心耳封堵器市场的成长。然而,植入左心耳封堵器也存在短期和长期风险。此外,设备植入程序并不能完全消除血栓的可能性,这阻碍了市场的成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球左心耳封堵器市场的各个细分市场进行了包容性评估。左心耳封堵器产业的成长和趋势为本研究提供了整体方法。
左心耳封堵器市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲左心耳封堵器市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。左心耳封堵器市场的主要参与者包括波士顿科学公司、LifeTech Scientific、Occlutech、强生公司、AtriCure Inc.、雅培实验室公司。的併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Left Atrial Appendage Closure Device Market is presumed to reach the market size of nearly USD 6.73 Billion by 2032 from USD 2.24 Billion in 2023 with a CAGR of 13.01% under the study period 2024-2032.
Left atrial appendage closure device helps prevent stroke by sealing off a small, unnecessary section of the heart called the left atrial appendage. The device is effective at eliminating the possibility of blood collecting in the left atrial appendage. The device is implanted by surgery. There are different LAA closure devices implanted by various methods performed under general anaesthesia, meaning the patient is asleep during the whole procedure. Device help can be achieved from an outside perspective or an inside blood exposed device.
Stroke is a serious risk for patients with atrial fibrillation. Patients with atrial fibrillation are at a higher danger of stroke if not appropriately treated. Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world. The growing prevalence of atrial fibrillation will be driving the growth of the market. Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market. However, implantation of an LAA occluder device also entails short-term and long-term risks. Also, device implantation procedures do not totally eliminate the possibility of blood clots which is hampering the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Left Atrial Appendage Closure Device. The growth and trends of Left Atrial Appendage Closure Device industry provide a holistic approach to this study.
This section of the Left Atrial Appendage Closure Device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Left Atrial Appendage Closure Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Left Atrial Appendage Closure Device market include Boston Scientific Corporation, LifeTech Scientific, Occlutech, Johnson & Johnson, AtriCure Inc., Abbott Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.